PITX2 and posterior cortical atrophy: A meta-analysis of seven studies (PCa n = 2185) confirmed its prognostic value for relapse (HR of 2.7; 5-year BCR-free survival: high vs. low PITX2 methylation: 71% vs. 90%) [76].